Revenue
2020
2021
2022
2023
2024
2025
PROCEPT BioRobotics Corp (PRCT)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $308.1M | $224.5M | $136.2M | $75.0M | $34.5M | $7.7M |
| Gross profit | $196.2M | $137.1M | $71.0M | $37.1M | $15.9M | −$1.3M |
| Research & development | $71.3M | $62.3M | $48.4M | $29.0M | $19.0M | $16.3M |
| Operating expenses | $300.1M | $233.7M | $180.2M | $117.8M | $70.0M | $46.5M |
| Operating income | −$103.9M | −$96.6M | −$109.2M | −$80.7M | −$54.2M | −$47.8M |
| EBITDAderived | −$97.5M | −$91.4M | −$105.4M | −$77.9M | −$50.8M | −$44.9M |
| Net income | −$95.6M | −$91.4M | −$105.9M | −$87.2M | −$59.9M | −$53.0M |
| Basic EPSper diluted share | -$1.72 | -$1.75 | -$2.24 | -$1.96 | -$3.63 | -$14.47 |
| Diluted EPSper diluted share | -$1.72 | -$1.75 | -$2.24 | -$1.96 | -$3.63 | -$14.47 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 8, 2026Form 4 | Nouri AlalehEVP, CLO, CORP. SEC. | SellCommon Stock | 285 | $28.48 | $8.1K | 105.1K |
| Jun 8, 2026Form 4 | Waters KevinEVP, CFO | SellCommon Stock | 357 | $28.48 | $10.2K | 151.2K |
| Jun 8, 2026Form 4 | Templin Barry LEVP, Chief Technology Officer | SellCommon Stock | 358 | $28.48 | $10.2K | 69.0K |
| Mar 19, 2026Form 4 · 10b5-1 | Nouri AlalehEVP, CLO, CORP. SEC. | SellCommon Stock | 2.3K | $26.15 | $61.0K | 105.4K |
| Mar 19, 2026Form 4 · 10b5-1 | Nouri AlalehEVP, CLO, CORP. SEC. | SellCommon Stock | 3.0K | $25.82 | $78.3K | 107.7K |